Berglund P, Sjöberg M, Garoff H, Atkins G J, Sheahan B J, Liljeström P
Department of Molecular Biology, Karolinska Institute, Novum, Huddinge, Sweden.
Biotechnology (N Y). 1993 Aug;11(8):916-20. doi: 10.1038/nbt0893-916.
In the recently developed Semliki Forest virus (SFV) DNA expression system, recombinant RNA encoding the viral replicase, and helper RNA molecules encoding the structural proteins needed for virus assembly are cotransfected into cells. Since the helper RNA lacks the sequence needed for its packaging into nucleocapsids, only recombinant RNAs should be packaged. We have found, however, that small amounts of replication-proficient SFV particles can still be produced. Here we describe the construction of a helper variant with a mutation in the gene encoding the viral spike protein such that its product cannot undergo normal proteolytic processing to activate viral entry functions. Hence, the recombinant stock is noninfectious, but may be activated by cleavage with chymotrypsin. When recombinant virus produced with the new helper was examined in a variety of assays, including sensitive animal tests, we were unable to detect any replication-competent SFV particles. We therefore conclude that this conditional expression system meets extremely stringent biosafety requirements.
在最近开发的辛德毕斯病毒(SFV)DNA表达系统中,编码病毒复制酶的重组RNA以及编码病毒组装所需结构蛋白的辅助RNA分子被共转染到细胞中。由于辅助RNA缺乏包装进核衣壳所需的序列,因此只有重组RNA会被包装。然而,我们发现仍能产生少量具有复制能力的SFV颗粒。在此,我们描述了一种辅助变体的构建,该变体在编码病毒刺突蛋白的基因中存在突变,使得其产物不能进行正常的蛋白水解加工以激活病毒进入功能。因此,重组病毒储备无感染性,但可用胰凝乳蛋白酶切割激活。当用新的辅助病毒产生的重组病毒在包括敏感动物试验在内的各种试验中进行检测时,我们未能检测到任何具有复制能力的SFV颗粒。因此,我们得出结论,这种条件表达系统符合极其严格的生物安全要求。